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Abstract: Numerous cases have been reported globally showing outbreaks, 
dissemination of infections and/or spoilage of medicinal products, food and 
other consumables that affects human life and may lead to death in some cases. 
One of the most critical measures of microbial contamination that should be 
taken into consideration is the use of proper disinfectant depending on the type 
of activities and the work load of the healthcare institution, subjects or media 
for microbial transfer and the affected population. The current study shows 
significant difference in sporicidal activity between two types of commercial 
peroxygen/Silver based disinfectants obtained from same manufacturer and 
delivered through same distributor at the same time. The peroxygen component 
in one of the disinfectant products is Hydrogen peroxide while in the other 
product is Peroxyacetic acid/Hydrogen Peroxide mixture. Preliminary rapid 
assessment of the disinfectants activity was required using the most resistance 
microbial form (bacterial spore) as a reference microorganism to challenge 
the biocidal products. Bacillus pumilus and B. subtilis spores were exposed 
to both disinfectants at three different concentrations levels covering the 
range recommended by the manufacturer: 1, 3 and 5% (v/v). The first 
formula did not exceed 0.5 logarithmic reduction (LR) even after 30 minutes. 
While the other product achieved more than two folds LR (more than 100 
times reduction in microbial population) after ten minutes contact time. 
Appropriate initial screening of biocidal activity in commercial disinfectants 
market is critical step that should be performed by the healthcare facilities 
before practical application. Otherwise, inefficient control on bioburden may 
lead to devastatingconsequences on human health. An initial, non-laborious, 
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time-saving and non-expensive screening test using the most resistance 
microorganisms is encouraged to be performed by healthcare facilities prior 
to practical application of disinfectant rather than reliance solely on random 
selection of biocidal agents using informational data without confirmatory 
experiments.
Keywords: Colloidal Silver, Peroxygen, Bacillus pumilus, Bacillus subtilis, 
logarithmic reduction.
1. INTRODUCTION
Microorganisms have been long known for their ability to survive and disseminate 
in different climates and even in the harsh conditions where other living organisms 
cannot live. At the same time, this survival capability of microbial life is a drawback 
to those professionals working in the healthcare industry (Clontz, 2008). Direct-
contact human products and materials such as food, drugs, cosmetics, medical 
devices and equipments are prone to microbial contamination from vast sources 
including human and environment and eventually gain access to the final consumer 
and/or patient (Denyer and Baird, 2007).
Disinfectants are prone to microbial contamination but at lower frequency 
compared to antiseptics, most probably due to ineffective application. There 
have been many reports for outbreaks and/or pseudo-outbreaks that have been 
originated from microbial contamination of disinfectant products (Weber 
et al., 2007). Examples include Bacillus cereus contamination of Ethanol, 
Glutaraldehyde loaded with Mycobacterium chelonae, Methylobacterium 
mesophilicum (Kressel and Kidd, 2001) and Mycobacterium species 
(Laskowski et al., 1977; Tyras et al., 1978). In addition, phenolic products 
were intruded with Pseudomonas species (Cragg and Andrews, 1969; Elliott 
and Masters.,1977; Newman et al., 1984), Pseudomonas aeruginosa (Baird 
and Shooter, 1976; Newman et al., 1984) and Alcaligenes faecalis (Simmon 
and Gardner, 1969) and quaternary ammonium compounds (QACs) were 
contaminated with Burkholderia cepacia (Dixon et al., 1976; Ebner et al., 
2005), Serratia marcescens (Ehrenkranz et al., 1980), Achromobacterxylos 
oxydans (Lehours et al., 2002) and Pseudomonas aeruginosa (Shickman et al., 
1959; Olson et al., 1999). Even Pseudomonas aeruginosa, Stenotrophomonas 
maltophilia (Vanholder et al., 1992) and Klebsiella oxytoca were found in 
Formaldehyde (Reiss et al., 2000).
Accordingly, proper sanitization and disinfection program should be 
implemented using appropriately and scientifically designed validation 
protocol (Sandle, 2014). Bacterial spores are one of the strongest forms that 
support survival of microorganisms in dormant state against hostile and 
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extreme environmental conditions (Russell, 1982; Lambert, 2004). While 
fungal spores are part of the normal life cycle of the fungi (Clontz, 2008).
Due to the above described challenges, the present work aimed to study 
the suitability of two commercially available sanitizing agents which were 
purchased from disinfectants market in Egypt. Moreover, a simple, inexpensive 
and non-laborious yet effective methodology was investigated which can be 
used within healthcare facilities to assess the suitability of specific disinfectant 
for particular application. The test should aid in providing decision within 
suitable time frame based on scientific approach.
2. MATERIALS AND METHODS
2.1. Subject of the study
Rapid assessment was requested for new two types of oxidizing disinfectant 
formulae which were obtained from the same manufacturer through the same 
supplier at the same time. These disinfectants should be used - based on the 
preliminary evaluation - in the routine sanitization and disinfection program of 
healthcare facility. Disinfectant samples were stored and prepared according 
to the manufacturer instructions. The antimicrobial components of the first 
disinfectant is Hydrogen Peroxide/Colloidal Silver (HP/Agc) and the other 
composed of Peroxyacetic acid (Peracetic acid)/Hydrogen Peroxide/ Colloidal 
Silver (PAA/HP/ Agc).
2.2. Preliminary neutralization parameters
The labeling system for traceability was as follows (disinfectant code/concentration 
% (v/v)/Bacillus spp.). The codes were given as follows: Bacillus pumilus(p), 
Bacillus subtilis(s), PAA/HP/ Agc (P) and HP/Agc (M). The basic principle of 
the preliminary neutralization study was conducted as described by Eissa and 
Nouby (2014). The method of conducting kinetics of spore inactivation study 
was performed as per reported detailed work (Eissa et al, 2014). Spore-forming 
microorganisms were purchased from ATCC (American Type Culture Collection, 
PO Box 1549 Manassas, VA_20108 USA, www.atcc.org). Standard strains that 
were used in the challenge test are B. subtilis subsp.spizizenii (ATCC 6633) and 
B. pumilus (ATCC 14884) and handled according to a standard procedure. All 
the culture media were purchased from OXOID (Basingstoke, Hampshire) and 
chemicals from Sigma-Aldrich (St. Louis, MO 63103).
2.3. Microbial suspension preparation
Standardized stable suspensions of test strains were prepared and used as stated 
by their suppliers. Seed-lot culture maintenance techniques (seed-lot systems)
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were used so that the viable microorganisms used for inoculation are not more 
than 5 passages removed from the original master seed-lot. All culture media 
used in the current study were subjected to growth promotion (GP) test as 
per compendial method (USP38-NF33, 2015). Suspensions were quantified by 
making serial dilutions and performing duplicate plate counts using conditions 
and media suitable for each microorganism. Microbial test suspensions should 
be used as soon as the results of serial dilutions could be enumerated using a 
digital colony counter (Digital Colony Counter Model: 361, Laxman Mahtre 
Rd. Navagaon, Dahisar West, Mumbai).
2.4. Instruments and tools
All organisms were stored at -80°C in a validated -86°C Ultra low temperature 
freezer (-86 Degree ULT Freezers, Qingdao Shandong, China) in validated 
cryogenic environment and reactivated only prior to the study conduction 
using standard method illustrated by the supplier. All media were sterilized 
by autoclaving in a steam sterilizer (FEDEGARI FOB3, Fedegari Autoclavi 
SpA, SS 235 km 8, 27010 Albuzzano (PV), Italy). All pH measurements and 
weighing procedures were done using Mettler-Toledo S20 SevenEasy™ pH 
Meter and XPE Analytical Balance respectively (Mettler-Toledo, LLC 1900 
Polaris Parkway Columbus, OH 43240). Plastic 9 mm sterile plates were 
purchased from Sterilin Limited (solaar house, 19 mercers row, Cambridge, 
UK). Biological safety cabinet (BSC) (Jouan MSC 9 Class II A2 BioSafety 
Cabinet, Thermo Fisher Scientific, 355 River Oaks Parkway, San Jose, 
California 95134) was used for all microbiological processing techniques.
2.5. Testing and technique
Environmental monitoring (EM) samples from surfaces and air within test 
area were taken according to Eissa, 2014 with every campaign test performed 
in BSC to monitor the quality of cleaning, disinfection and aseptic behavior 
under laminar air flow conditions (Eissa, 2014). Bacterial visualization was 
facilitated using colorless Triphenyltetrazolium Chloride (TTC) dye which 
is reduced from colorless to red insoluble1,3,5-triphenylformazan (TPF) in 
viable cells by various dehydrogenasesas indicated by some manufacturers of 
culture media (BD Difco™, 2016). Cultures purity and identity were confirmed 
by isolation and identification (Estridge et al., 2000; Ashour et al, 2011). 
Acceptance criteria of the test results were decided based on what is stated 
(Clontz, 2008). Acceptance criteria for significance of microbial reduction and 
spore count reduction were decided based on United States Pharmacopoeia 











All statistical analysis tests and the kinetics of microbial death were performed 
using Graph Pad Prism version 6.01. Any interpretation or complex calculation 
was performed using Microsoft Excel 2007.
3. RESULTS AND DISCUSSION
Figure 1 showed that disinfectant P could achieve more than two logarithmic 
reduction (LR) within ten minutes and hence met the compendial requirement 
for sanitizing agents. While M was not able to meet this requirement even after 
30 minutes, although it has been claimed to be effective against wide spectrum 
of microorganisms including spore-formers. On the other hand, Table 1 
demonstrated that at all points and concentrations P had significant impact 
on bioburden reduction as LR exceeded 0.3 to 0.5 variability from the initial 
values. Aberrant results required further analysis, statistical comparison was 
performed using One-Way Analysis Of Variance (ANOVA) at p<0.05.This is 
in contrast of M as there was slight difference observed at 3% dilution (v/v), 
which may indicate that the slow action requires longer time. Strangely, an
Figure 1: Inactivation kinetics of bacterial spores exposed to peroxygens and 
expressed as logarithmic reduction (LR to base ten) from the initial inoculum, 
with dashed line showing the acceptance criterion.
EISSA, M.E. 
166
exception odd results of M 5% (v/v) concentration may be excluded although 
it was not found to differ significantly from the other values of M. It is not clear 
if M can affect spore population significantly after 30 minutes or not, as it is 
known that HP is slow acting sporicidal disinfectant in contrast to PAA (Cotruvo 
et al., 1999; WHO, 2004; Tamime, 2009; LabSafety, 2009). However, it will 
not be practical to allow for longer contact time because it is not reasonable 
for activities and heavy and frequent work load. Accordingly, M was excluded 
from further applications or studies. Meanwhile, P was incorporated in further 
antimicrobial studies parallel to its application at 1% (v/v) concentration for 
ten minutes on utensils and surfaces in the healthcare buildings.
Sagripanti and Bonifacino, 1996 have demonstrated that the rate of spores 
inactivation by PAA are much higher than that of HP. So, it is not strange in 
view of other researchers results to find such contrast between both products. 
Based on this outcome proper selection and application of disinfectant 
should be tested and evaluated before its practical use, regardless of the 
labelled spectrum of activity and use that are claimed by the manufacturer 
of the disinfectant. However, the limitation of application of this challenge 
test is the large array of microorganisms displayed by guidelines of this test 
(Clontz, 2008), which may be hindering barrier for application especially for 
healthcare facilities in the developing countries. Accordingly, very limited 
microorganisms can be carefully selected (as shown in the current study) to 
represent the most challenging microbes for specific industry and/or activity. 
The microorganisms can be referred to as “marker” or “indicator” microbe for 
specific situation.
Table 1: Comparative study for the significance of the reduction of spore 
population at different concentrations intervals covering the recommended 
range of dilutions.
Microorganism Time (min.)   M1% M3% M5% P1% P3% P5%
10 0.054 0.097 0.073 0.000 0.000 0.000
Bacillus pumilus 20 0.117 0.295 0.150*   2.222 2.362 2.089
30 0.327 0.398 0.398 2.434 3.760 3.732
Bacillus subtilis 10 0.230 0.291 1.009*   2.146 2.102 2.178
20 0.244 0.358 1.022*   2.555 3.523 3.292
*Odd results required further analysis using One-Way Analysis Of Variance (ANO-
VA) at p<0.05 to compare it with the other dilutions of the same disinfectant (M) and 
the difference was found to be not significant.
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Disinfectant selection screening study showed that PAA/HP/Agc combination 
was very effective as sporicidal agent and was capable in meeting the acceptance 
criteria within ten minutes contact time with spores by achieving more than 
100 reduction folds in the recovered population in CFU. Accordingly, it can 
be applied efficiently as biocidal agent to control bioburden at the dedicated 
concentration range 1-5% (v/v). On the other, HP/Agc formula from the same 
manufacturer was not able to yield effective results within 30 minutes of contact. 
Thus, it cannot be used safely to control microbial population when relatively 
fast action is required. The present case highlights the importance of conducting 
preliminary evaluation study of commercially available sanitizing agents before 
using it blindly, even if the instructions for storage, preparation and dilution 
were done literally as recommended by the manufacturer. The availability of 
varieties of antimicrobial products in the open world trading market requires 
careful and controlled approach from healthcare providers in selecting and using 
biocidal products that impact consumer health and the quality of life.
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